Navigation Links
The Female Health Company Reports 37% Revenue Growth and Record Profits for First Quarter of FY2008
Date:2/13/2008

eflects the growing role that our female condoms are playing in the global battle against HIV/AIDS. Acceptance of our second-generation FC2 Female Condom(R) has been excellent."

"In December, 2007, we completed the expansion of FC2 production capacity in Malaysia to four lines with an annual capacity of 30 million units in addition to FC production facility in London. A fifth end-stage FC2 production line, located in Cochin, India, with an annual capacity of 7.5 million units, began producing condoms in December 2007, under the auspices of our business partnership with Hindustan Latex Limited."

"We ended the first quarter with the strongest balance sheet in our history, with no debt outstanding, approximately $1.8 million of cash in the bank, and a current ratio of 3.5-to-1.0. Based upon information currently available to the Company, we believe Fiscal 2008 will be another record year in terms of revenues and earnings."

As previously announced, the Female Health Company will host an investor conference call at 11:00 a.m. EST today, February 13, 2008. Shareholders and other interested parties may participate in the conference call by dialing 888-603-6873 (international participants dial 973-582-2706 and referencing the conference code 32404579, a few minutes before 11:00 a.m. EST on February 13, 2008. A replay of the call will be available through February 27, 2008 by dialing 800-642-1687 (international callers dial 706-645-9291) and referencing the conference code 32404579.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC Female Condom(R), which is primarily distributed by public health organizations and donor groups in over 90 developing countries around the world. World-wide, the Female Condom is available in various programs in 116 countries. The Company owns certain worldwide rights to the FC Female Condom(R), including patents that have been issued in the Un
'/>"/>

SOURCE The Female Health Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. The Female Health Company Schedules First Quarter Conference Call for February 13, 2008
2. The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application
3. Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars
4. Females decide whether ambitious males float or flounder
5. Cancer-Suppressing Gene Tied to Female Fertility
6. Exercise May Help Female Astronauts Stay Strong
7. The Female Health Company to Present at Wall Street Analyst Forum Wednesday, November 28, 2007
8. The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 2007
9. Some Female Athletes Risking Weaker Bones
10. Female Blood Donor Concern May Be Unfounded
11. Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Woodloch Pines, an ... has been selected by TripAdvisor as the number one best ... 6th best in the world for their annual Travelers’ Choice ... travel community . The website is home to millions of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... number one in the nation in cardiology and GI ... for 2008, BOSTON, May 29 Children,s Hospital ... pediatric hospitals in the country,according to U.S.News & World ... Since the magazine began ranking hospitals 19 years ago, ...
... 5; Cancer program ... in Top 10 ... Bay Area, STANFORD, Calif., May 29 Once again, Lucile Packard,Children,s Hospital ... annual America,s Best Children,s Hospitals issue hitting,newsstands June 2, the magazine places Lucile ...
... to 66% increased risk of disease after operation , , ... anti-rejection drug sirolimus may lead to increased risk of ... data on about 20,000 Medicare patients who had kidney ... patients had diabetes before their kidney transplant. Compared to ...
... Sales Managers and executives,often face questions such as: ... middle-ranking performers, Inducements have to stand out to,engender ... is a summary of a research,presentation that evaluates ... and intangible rewards used in sales recognition programs. ...
... 1 or type 2 diabetes who self-monitor their blood ... adjust treatment regimens can achieve improved glucose control, according ... Special Supplement to the June 2008 issue (Volume 10, ... journal published by Mary Ann Liebert, Inc. ( www.liebertpub.com ...
... May 29 Martek Biosciences,Corporation (Nasdaq: MATK ) ... Annual Needham & Company Biotechnology and Medical Technology,Conference in ... - 12, 2008 at,the New York Palace Hotel. Peter ... 12, 2008 at 1:30 p.m. Eastern Time., A ...
Cached Medicine News:Health News:Children's Hospital Boston Ranked Number One in New England 2Health News:Children's Hospital Boston Ranked Number One in New England 3Health News:U.S.News 2008 'Best Hospitals' Issue Again Ranks Packard Children's as One of Nation's Best 2Health News:Anti-Rejection Drug May Boost Diabetes in Kidney Transplant Patients 2Health News:Best Practices in Sales Recognition 2Health News:Special supplement on self-monitoring of blood glucose in diabetes technology & therapeutics 2
(Date:1/23/2015)... HILL, N.C. , Jan. 23, 2015 For the ... are in dealing with payers. Likewise, the importance of the ... - will only continue to grow as payer formularies and ... access therapies. At the same time, managed markets ...
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ... "Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends ... Video communication has been the topic of fascination ... the United States and the Soviet Russia. Earlier ...
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ... the "Urinary Catheters Market (Indwelling or Foley Catheters, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... , At present, the global market for ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3
... Data Show Bifeprunox Maintained Stability,Significantly Longer than ... Profile Comparable with Placebo , MARIETTA, Ga. ... Solvay,Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of ... results on,bifeprunox, an investigational treatment for adult ...
... 2007 /PRNewswire-FirstCall/ -- Forest,Laboratories, Inc. and Cypress ... from a 1,196 patient randomized,three month, double-blind, ... therapeutic effects of,milnacipran as a treatment of ... only been able to review initial top-line,results ...
Cached Medicine Technology:New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 2Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 3Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 4Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 5Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 6
... blood oximeters provide cardiologists with critical ... a patient's blood. The Oxicom series ... over a half-million saturation samples measured ... cost-effective oxygen saturation readings in less ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
Medicine Products: